Daxor to Showcase New Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress, Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay.

Daxor Corporation will showcase a new, portable blood volume analyzer at the Society for Critical Care Medicine's 2026 Critical Care Congress. The device delivers rapid, lab-quality results and positions Daxor to address high costs associated with adult ICU admissions in the US, which exceed $100 billion annually. Studies have shown BVA can reduce mortality by 66% and alter fluid and red blood cell interventions in 44% of cases.